Anti-TRAM1 monoclonal antibody
Pre-made anti-TRAM1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to TRAM1/TRAM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2170-Ab-1/ GM-Tg-hg-IP2170-Ab-2 | Anti-Human TRAM1 monoclonal antibody | Human |
GM-Tg-rg-IP2170-Ab-1/ GM-Tg-rg-IP2170-Ab-2 | Anti-Rat TRAM1 monoclonal antibody | Rat |
GM-Tg-mg-IP2170-Ab-1/ GM-Tg-mg-IP2170-Ab-2 | Anti-Mouse TRAM1 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2170-Ab-1/ GM-Tg-cynog-IP2170-Ab-2 | Anti-Cynomolgus/ Rhesus macaque TRAM1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2170-Ab-1/ GM-Tg-felg-IP2170-Ab-2 | Anti-Feline TRAM1 monoclonal antibody | Feline |
GM-Tg-cang-IP2170-Ab-1/ GM-Tg-cang-IP2170-Ab-2 | Anti-Canine TRAM1 monoclonal antibody | Canine |
GM-Tg-bovg-IP2170-Ab-1/ GM-Tg-bovg-IP2170-Ab-2 | Anti-Bovine TRAM1 monoclonal antibody | Bovine |
GM-Tg-equg-IP2170-Ab-1/ GM-Tg-equg-IP2170-Ab-2 | Anti-Equine TRAM1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2170-Ab-1/ GM-Tg-hg-IP2170-Ab-2; GM-Tg-rg-IP2170-Ab-1/ GM-Tg-rg-IP2170-Ab-2; GM-Tg-mg-IP2170-Ab-1/ GM-Tg-mg-IP2170-Ab-2; GM-Tg-cynog-IP2170-Ab-1/ GM-Tg-cynog-IP2170-Ab-2; GM-Tg-felg-IP2170-Ab-1/ GM-Tg-felg-IP2170-Ab-2; GM-Tg-cang-IP2170-Ab-1/ GM-Tg-cang-IP2170-Ab-2; GM-Tg-bovg-IP2170-Ab-1/ GM-Tg-bovg-IP2170-Ab-2; GM-Tg-equg-IP2170-Ab-1/ GM-Tg-equg-IP2170-Ab-2 |
Products Name | Anti-TRAM1 monoclonal antibody |
Format | mab |
Target Name | TRAM1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-TRAM1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2170-Ag-1 | Recombinant multi-species TRAM1/ PNAS8/ TRAM protein |
ORF Viral Vector | pGMLP002511 | human TRAM1 Lentivirus plasmid |
ORF Viral Vector | vGMLP002511 | human TRAM1 Lentivirus particle |
ORF Viral Vector | pGMLPm001840 | mouse Tram1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001840 | mouse Tram1 Lentivirus particle |
Target information
Target ID | GM-IP2170 |
Target Name | TRAM1 |
Gene ID | 23471,72265,312903,693963,403948,101097373,281546,100051585 |
Gene Symbol and Synonyms | 1810049E02Rik,PNAS8,TRAM,TRAM1,TRAMP |
Uniprot Accession | Q15629,Q5XI41,Q01685,Q9GKZ4 |
Uniprot Entry Name | TRAM1_HUMAN,TRAM1_RAT,TRAM1_CANLF,TRAM1_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | Prostate Cancer |
Gene Ensembl | ENSG00000067167 |
Target Classification | N/A |
The target: TRAM1, gene name: TRAM1, also named as PNAS8, TRAM, TRAMP. This gene encodes a multi-pass membrane protein that is part of the mammalian endoplasmic reticulum. The encoded protein influences glycosylation and facilitates the translocation of secretory proteins across the endoplasmic reticulum membrane by regulating which domains of the nascent polypeptide chain are visible to the cytosol during a translocational pause. [provided by RefSeq, Oct 2009].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.